Side-by-side comparison of AI visibility scores, market position, and capabilities
AI outbound recruiting platform with 250M+ candidate database; automated talent sourcing campaigns achieving 30-40% response rates competing with LinkedIn Recruiter and Gem.
Weekday is an AI-powered B2B recruiting platform that runs outbound talent sourcing campaigns — searching its database of 250 million+ professionals in the US and India with verified contact data to identify and reach passive candidates who aren't actively applying to jobs. Founded in 2021 in Bengaluru, India by Chetan Dalal, Anubhav Malik, and Amit Singh, Weekday is backed by Y Combinator and raised $2.32 million in seed funding led by Venture Highway, achieving profitability in 2024 while approaching $1 million in annualized revenue.\n\nWeekday's platform works differently from LinkedIn Recruiter or job boards — rather than posting jobs and waiting for applications, Weekday builds automated outreach campaigns targeting specific candidate profiles. Recruiters define the ideal candidate attributes (skills, experience level, company background, location), and Weekday's AI identifies matching profiles and generates personalized outreach messages. The 30-40% campaign response rates Weekday achieves significantly outperform cold outreach benchmarks, reflecting the quality of targeting and message personalization.\n\nIn 2025, Weekday competes with LinkedIn Recruiter (the dominant passive candidate search tool), SeekOut, Gem, and Findem for AI-powered talent sourcing and outbound recruiting tools. The passive candidate market is particularly valuable for technical roles (software engineering, data science, product management) where the best candidates are rarely actively job searching. Weekday's India+US database gives it strong coverage in the tech talent markets most in demand by technology companies. The 2025 strategy focuses on expanding the contact database depth, adding more AI personalization to outreach campaigns, and growing from SMB recruiting teams to enterprise talent acquisition departments at larger technology companies.
Global pharma company with $55B 2024 revenue; successfully diversifying beyond Humira with Skyrizi, Rinvoq, and $8.7B Cerevel neuroscience acquisition.
AbbVie is a global research-based biopharmaceutical company focused on developing treatments for complex and serious diseases including immunology, oncology, neuroscience, aesthetics, and eye care. Spun off from Abbott Laboratories in 2013 and headquartered in North Chicago, Illinois, AbbVie rapidly became one of the world's top pharmaceutical companies on the strength of Humira — the world's best-selling drug for over a decade with peak annual sales exceeding $20 billion. AbbVie is listed on the NYSE and is a component of the S&P 500 and Dow Jones Industrial Average.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.